Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2019 Nov;69(5):599–606. doi: 10.1097/MPG.0000000000002482

Table 3:

Imaging features of pancreatitis

Variables Diabetes=Yes (n=24) Diabetes=No (n=373) OR (95% CI) of Diabetes
Imaging studies performed
 ERCP 7 (29%) 153 (41%) 0.59 (0.24, 1.46)
 CT scan 10 (42%) 164 (44%) 0.91 (0.39, 2.10)
 MRI 11 (46%) 249 (67%) 0.42 (0.18, 0.97)
 MRCP 15 (63%) 278 (75%) 0.57 (0.24, 1.34)
 EUS 0 (0%) 38 (10%) 0.00 (0.00, 1.22)
Findings (CT/MRI)
 Focal Acute Pancreatitis 3/15 (20%) 43/220 (16%) 1.28 (0.22, 5.02)
 Inflammatory changes in Pancreas 6/15 (40%) 98/298 (37%) 1.14 (0.39, 3.31)
 Pancreatic Gland Enlargement 5/15 (33%) 69/267 (26%) 1.43 (0.37, 4.80)
 Pancreatic Atrophy Present 8/16 (50%) 58/269 (22%) 3.64 (1.13, 11.59)
 Calcifications in Pancreas present 1/15 (7%) 22/268 (8%) 0.80 (0.02, 5.75)
 Duct Irregularities 2/16 (12%) 92/267 (34%) 0.27 (0.06, 1.22)
 Pancreatic duct dilatation present 3/16 (19%) 97/268 (36%) 0.41 (0.11, 1.46)
 Lesions present in the pancreas 0/16 (0%) 9/272 (3%) 0.00 (0.00, 7.04)
 Gallstones/Sludge 1/16 (6%) 23/266 (9%) 0.70 (0.02, 5.01)
 Intraheptic biliary dilatation 1/16 (6%) 27/269 (10%) 0.60 (0.01, 4.20)
 Changes suggestive of cirrhosis and/or portal hypertension 2/16 (12%) 17/266 (6%) 2.09 (0.21, 10.33)
Findings (CT/MRI/ MRCP/ ERCP)
 Pancreatic duct obstruction (stricture) 1/22 (5%) 63/321 (20%) 0.20 (0.00, 1.26)
 CBD stricture (Intrapancreatic portion) 0/22 (0%) 17/334 (5%) 0.00 (0.00, 2.97)
 Dilated CBD 5/22 (23%) 49/336 (15%) 1.72 (0.47, 5.15)
 CBD Stone 0/22 (0%) 20/337 (6%) 0.00 (0.00, 2.49)
Findings (CT/MRI/EUS)
 Peripancreatic inflammation/fat stranding 7/15 (47%) 90/274 (33%) 1.79 (0.63, 5.09)
Findings (CT/MRI/MRCP/ ERCP /EUS)
 Cysts/Pseudocysts 4/22 (18%) 50/338 (15%) 1.28 (0.30, 4.11)
Findings (MRCP/ERCP)
 Main Pancreatic Duct - Abnormal 7/18 (39%) 149/291 (51%) 0.61 (0.23, 1.61)
 Abnormal Side Branches 4/16 (25%) 76/284 (27%) 0.91 (0.21, 3.13)
 Intraductal filling defects of Calculi 2/16 (12%) 54/290 (19%) 0.62 (0.07, 2.85)

ERCP= Endoscopic retrograde cholangiopancreatography; CT = Computed tomography; MRI= Magnetic resonance imaging; MRCP= Magnetic resonance cholangiopancreatography; EUS= Endoscopic ultrasound;